# Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM

> **NCT01694173** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 28 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** Stem cell therapy- SPD artery
- **OTHER:** Stem cell therapy- splenic artery
- **OTHER:** Stem cell therapy-intravenous
- **OTHER:** Normal saline placebo -sham procedure

## Key facts

- **NCT ID:** NCT01694173
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2012-08
- **Final completion:** 2013-02
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2012-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694173, "Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01694173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*